Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alimera Sciences Inc (NASDAQ:ALIM)

1.45
Delayed Data
As of Jul 21
 -0.13 / -8.23%
Today’s Change
1.01
Today|||52-Week Range
2.40
+34.26%
Year-to-Date

Today’s Trading

Previous close1.58
Today’s open1.59
Day’s range1.42 - 1.59
Volume924,292
Average volume (3 months)404,474
Market cap$94.1M
Dividend yield--
Data as of 3:59pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)+8.70%
Earnings growth (this year)+69.05%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+53.01%
P/E ratioNM
Price/Sales1.66
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARLZAralez Pharmaceutica...-0.02-1.38%
OPHTOphthotech Corp-0.06-2.23%
CEMIChembio Diagnostics ...0.000.00%
ZFGNZafgen Inc-0.02-0.57%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$34.3M
Annual profit (last year)-$33.2M
Net profit margin-96.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts